BeOne Medicines (BEIGF) EBT Margin (2015 - 2026)
BeOne Medicines (BEIGF) reported EBT Margin of 17.13% for Q1 2026, up 1526.0% year-over-year from 1.05% in Q1 2025, and up 71.94% quarter-over-quarter from 9.96% in Q4 2025.
BeOne Medicines (BEIGF) EBT Margin (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of EBT Margin data on file, last reported at 17.13% in Q1 2026.
- EBT Margin for Q1 2026 came in at 17.13%, up 1526.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.42% (up 1785.0% YoY), and the FY2025 annual result was 7.8%, up 2179.0% from the prior year.
- EBT Margin advanced to 17.13% in Q1 2026 per BEIGF's latest filing, from 9.96% in the prior quarter.
- Over five years, EBT Margin peaked at 29.35% in Q3 2023 and troughed at 163.24% in Q2 2022.
- A 5-year average of 43.14% and a median of 11.4% in 2024 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 14759 bps in 2022, then surged 17156 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 113.38% in 2022, then soared by 51 bps to 55.29% in 2023, then soared by 86 bps to 7.57% in 2024, then jumped by 232 bps to 9.96% in 2025, then jumped by 72 bps to 17.13% in 2026.
- Business Quant data shows BEIGF's EBT Margin at 17.13% in Q1 2026, 9.96% in Q4 2025, and 10.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 17.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.13% |
| Dec 31, 2025 | 9.96% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | 7.57% |
| Mar 31, 2025 | 1.87% |
| Dec 31, 2024 | -7.57% |
| Sep 30, 2024 | -9.81% |
| Jun 30, 2024 | -11.40% |
| Mar 31, 2024 | -32.39% |
| Dec 31, 2023 | -55.29% |
| Sep 30, 2023 | 29.35% |
| Jun 30, 2023 | -61.73% |
| Mar 31, 2023 | -75.24% |
| Dec 31, 2022 | -113.38% |
| Sep 30, 2022 | -142.21% |
| Jun 30, 2022 | -163.24% |
| Mar 31, 2022 | -137.38% |
| Dec 31, 2021 | -283.22% |
| Sep 30, 2021 | -209.78% |
| Jun 30, 2021 | -320.40% |